Literature DB >> 6208694

[Antiviral and therapeutic action of protease inhibitors in viral infections: experimental and clinical observations].

O P Zhirnov, A V Ovcharenko, A G Bukrinskaia, L P Ursaki, L A Ivanova.   

Abstract

The effect of protease inhibitors (gordox, contrycal, epsilon-aminocapronic acid) on the development of influenza virus-induced infectious process was studied. Administration of the above-mentioned drugs exerted a marked antiviral and therapeutic effect both in animal experiments and in treatment of children suffering from influenza. Electron microscopic examinations of lungs from influenza virus-infected animals treated with protease inhibitors revealed definite decrease in the number of virus particles and significant diminution of pathological lesions; the changes were noted which indicated activation of the body immune response. The use of a protease inhibitor, epsilon-aminocapronic acid, in children with influenza shortened the duration of influenza virus antigens persistence in the nasopharyngeal epithelium and reduced the duration of the disease symptoms by 1 1/2-2-fold. Administration of epsilon-aminocapronic acid in inhalations exerted most effective antiviral and therapeutic effect. The results obtained demonstrate the possibility of influenza treatment with inhibitors of proteolytic enzymes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208694

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  5 in total

1.  TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.

Authors:  Stephanie Bertram; Ilona Glowacka; Paulina Blazejewska; Elizabeth Soilleux; Paul Allen; Simon Danisch; Imke Steffen; So-Young Choi; Youngwoo Park; Heike Schneider; Klaus Schughart; Stefan Pöhlmann
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.

Authors:  Mahmoud M Bahgat; Paulina Błazejewska; Klaus Schughart
Journal:  Virol J       Date:  2011-01-20       Impact factor: 4.099

3.  Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts.

Authors:  Stephanie Bertram; Adeline Heurich; Hayley Lavender; Stefanie Gierer; Simon Danisch; Paula Perin; Jared M Lucas; Peter S Nelson; Stefan Pöhlmann; Elizabeth J Soilleux
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

Review 4.  Novel insights into proteolytic cleavage of influenza virus hemagglutinin.

Authors:  Stephanie Bertram; Ilona Glowacka; Imke Steffen; Annika Kühl; Stefan Pöhlmann
Journal:  Rev Med Virol       Date:  2010-09       Impact factor: 6.989

5.  High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination.

Authors:  O P Zhirnov
Journal:  J Med Virol       Date:  1987-02       Impact factor: 2.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.